Individual participant data meta‐analysis to examine interactions between treatment effect and participant‐level covariates: Statistical recommendations for conduct and planning
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Precision medicine research often searches for treatment‐covariate interactions, which refers to when a treatment effect (eg, measured as a mean difference, odds ratio, hazard ratio) changes across values of a participant‐level covariate (eg, age, gender, biomarker). Single trials do not usually have sufficient power to detect genuine treatment‐covariate interactions, which motivate the sharing of individual participant data (IPD) from multiple trials for meta‐analysis. Here, we provide statistical recommendations for conducting and planning an IPD meta‐analysis of randomized trials to examine treatment‐covariate interactions. For conduct, two‐stage and one‐stage statistical models are described, and we recommend: (i) interactions should be estimated directly, and not by calculating differences in meta‐analysis results for subgroups; (ii) interaction estimates should be based solely on within‐study information; (iii) continuous covariates and outcomes should be analyzed on their continuous scale; (iv) nonlinear relationships should be examined for continuous covariates, using a multivariate meta‐analysis of the trend (eg, using restricted cubic spline functions); and (v) translation of interactions into clinical practice is nontrivial, requiring individualized treatment effect prediction. For planning, we describe first why the decision to initiate an IPD meta‐analysis project should not be based on between‐study heterogeneity in the overall treatment effect; and second, how to calculate the power of a potential IPD meta‐analysis project in advance of IPD collection, conditional on characteristics (eg, number of participants, standard deviation of covariates) of the trials (potentially) promising their IPD. Real IPD meta‐analysis projects are used for illustration throughout.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Approximate Distribution of Estimates of Variance Components
Satterthwaite, F. E. (1946) · Biometrics Bulletin · doi:10.2307/3002019 · Cited by 4,373
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Interpretation of random effects meta-analyses
Riley, R. D., Higgins, J. P. T., & Deeks, J. J. (2011) · BMJ · doi:10.1136/bmj.d549 · Cited by 2,884 · cited 2×
“4σ2 i (∑ j∈Ti z′2 ij + ∑ j∈Ci z′2 ij )⎟⎟⎟⎠ ⎞⎟⎟⎟⎠ , (20) and as before we could replace ∑ni j=1 z ′2 ij with niσ(2) zi , and similarly ∑ j∈Ti z′2 ij and ∑ j∈Ci z′2 ij could be replaced with nTiσ 2 Tizi and nCiσ 2 Cizi , respectively.”
BackgroundSelf-citationInternal validation of predictive models
Steyerberg, E. W., Harrell, F. E., Borsboom, G. J. J. M., Eijkemans, M. J. C., Vergouwe, Y., & Habbema, J. D. F. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00341-9 · Cited by 2,746
A Re-Evaluation of Random-Effects Meta-Analysis
Higgins, J. P. T., Thompson, S. G., & Spiegelhalter, D. J. (2009) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2008.00552.x · Cited by 2,569
Steyerberg, E. W. (2009) · Statistics for Biology and Health · doi:10.1007/978-0-387-77244-8 · Cited by 1,491
Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
Altman, D. G., Lausen, B., Sauerbrei, W., & Schumacher, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.829 · Cited by 1,143
VanderWeele, T. J., & Knol, M. J. (2014) · Epidemiologic Methods · doi:10.1515/em-2013-0005 · Cited by 1,127
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
Sun, X., Briel, M., Walter, S. D., & Guyatt, G. H. (2010) · BMJ · doi:10.1136/bmj.c117 · Cited by 808 · cited 2×
“The estimate of γWA from model (12) will be more precise than the estimate of γW from”
BackgroundA refined method for the meta-analysis of controlled clinical trials with binary outcome
Hartung, J., & Knapp, G. (2001) · Statistics in Medicine · doi:10.1002/sim.1009 · Cited by 775
Subgroup analyses in randomized trials: risks of subgroup-specific analyses;
Brookes, S. T., Whitely, E., Egger, M., Smith, G. D., Mulheran, P. A., & Peters, T. J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.08.009 · Cited by 775
Multivariate meta-analysis for non-linear and other multi-parameter associations
Gasparrini, A., Armstrong, B., & Kenward, M. G. (2012) · Statistics in Medicine · doi:10.1002/sim.5471 · Cited by 772
Stijnen, T., Hamza, T. H., & Özdemir, P. (2010) · Statistics in Medicine · doi:10.1002/sim.4040 · Cited by 757
Steyerberg, E. W., Borsboom, G. J. J. M., van Houwelingen, H. C., Eijkemans, M. J. C., & Habbema, J. D. F. (2004) · Statistics in Medicine · doi:10.1002/sim.1844 · Cited by 552
Burke, D. L., Ensor, J., & Riley, R. D. (2017) · Statistics in Medicine · doi:10.1002/sim.7141 · Cited by 538
Self-citationMultivariate meta‐analysis: Potential and promise
Jackson, D., Riley, R., & White, I. R. (2011) · Statistics in Medicine · doi:10.1002/sim.4172 · Cited by 530
Self-citationMultivariate Random-effects Meta-regression: Updates to Mvmeta
White, I. R. (2011) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1101100206 · Cited by 400
Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials
Lipkovich, I., Dmitrienko, A., & B., R. (2017) · Statistics in Medicine · doi:10.1002/sim.7064 · Cited by 291
Mastering variation: Variance components and personalised medicine
Senn, S. (2016) · Statistics in Medicine · doi:10.1002/sim.6739 · Cited by 205
Statistical pitfalls of personalized medicine
Senn, S. (2018) · Nature · doi:10.1038/d41586-018-07535-2 · Cited by 174
Can meta-analysis help target interventions at individuals most likely to benefit?
Thompson, S. G., & Higgins, J. P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)70200-2 · Cited by 174 · cited 4×
“Note that random-effects meta-analysis model (5) allows for between-study heterogeneity in the true treatment -covariate interaction.”
MethodInfluentialWallach, J. D., Sullivan, P. G., Trepanowski, J. F., Sainani, K. L., Steyerberg, E. W., & Ioannidis, J. P. A. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9125 · Cited by 148 · cited 4×
“In models (9) to (11) each of the “nuisance” parameters (ie, the αi, λ0i(t), β1i, β2i, and β3i parameters which are not of primary interest) are stratified by trial, and random effects are placed only on the within-study interaction.”
BackgroundMethodInfluentialHua, H., Burke, D. L., Crowther, M. J., Ensor, J., Tudur Smith, C., & Riley, R. D. (2017) · Statistics in Medicine · doi:10.1002/sim.7171 · Cited by 113
Self-citationSchuit, E., Li, A. H., & Ioannidis, J. P. A. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyy239 · Cited by 27
Cited by
Galante, J., Friedrich, C., Collaboration of Mindfulness Trials (CoMinT), Aeamla-Or, N., Arts-de Jong, M., Barrett, B., Bögels, S. M., Buitelaar, J. K., Checovich, M. M., Christopher, M. S., et al. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00081-5 · Cited by 113
Louise, J., Poprzeczny, A. J., Deussen, A. R., Vinter, C., Tanvig, M., Jensen, D. M., Bogaerts, A., Devlieger, R., McAuliffe, F. M., Renault, K. M., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01995-6 · Cited by 62
Gallardo-Gómez, D., del Pozo-Cruz, J., Pedder, H., Alfonso-Rosa, R. M., Álvarez-Barbosa, F., Noetel, M., Jasper, U., Chastin, S., Ramos-Munell, J., & del Pozo Cruz, B. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2022-106409 · Cited by 59
Collaborators, T. R., Brady, M. C., Ali, M., VandenBerg, K., Williams, L. J., Williams, L. R., Abo, M., Becker, F., Bowen, A., Brandenburg, C., et al. (2022) · International Journal of Stroke · doi:10.1177/17474930221097477 · Cited by 54
“8,9 Limitations to aggregate data meta-syntheses include the risk of outcome reporting bias, 10 restricted inclusion of language data, and the need to synthesize various clinical language assessments into a standardized mean difference 11,12 , making clinical interpretation and application of…”
Method
Metadata
- Authors
- Riley, R. D., Debray, T. P. A., Fisher, D., Hattle, M., Marlin, N., Hoogland, J., Gueyffier, F., Staessen, J. A., Wang, J., Moons, K. G. M., Reitsma, J. B., & Ensor, J.
- Venue
- Statistics in Medicine
- Publisher
- Wiley
- Published
- 2020-04-30
- Volume
- 39
- Issue
- 15
- Pages
- 2115-2137
- ISSN
- 0277-6715 (ISSN-L)
- 1097-0258
- OpenAlex
- W3021476651
- Cited by
- 175
- References
- 24
- FWCI
- 14.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.